NF‐κB not only enhances ABCG2 transcription but also promotes its membrane localization, facilitating the development of multidrug resistance (MDR) in various cancers, including acute myeloid leukemia and non‐small cell lung cancer (NSCLC) [42, 43]. This evidence concerns the gene ABCG2 and cancer.